MYOV stock: buy or sell?

MYOV stock price: $12.04 0.25% At close on May 14th, 2020

Updated on:
May 14th, 2020

2

After sliding a chilling -10.82% yesterday, Myovant Sciences closed today at $12.04 and stayed steady a tiny 0.25%. On May/6 MYOV skyrocketed an extraordinary 8.38%.

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases.

Should I buy MYOV stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading plan that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Myovant Sciences stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Myovant Sciences stock a buy?

Banks and financial institutions post stock ratings everyday. Unfortunately, we couldn't detect any rating for MYOV stock for the last month.

MYOV stock analysis

Daily outlook

After sliding a chilling -10.82% yesterday, Myovant Sciences closed today at $12.04 and stayed steady a tiny 0.25%.

After sliding a chilling -10.82% yesterday, Myovant Sciences closed today at $12.04 and stayed stable a tiny 0.25%. For the last 35 days when MYOV stock price broke up the SMA200d line, it gained $3.29 (37.60%). Since SMA100d and SMA200d crossed up on February, MYOV price slid a -4.37%.

MYOV stock chart (daily)

Weekly outlook

After boosting an extraordinary 11.93% in a week last week, Myovant Sciences closed this week at $12.04 and plummed a shocking -4.90%.

Since price and SMA40w lines crossed up by mid April, MYOV climbed $2.44 (25.42%). Since SMA20w and SMA40w crossed up late January, MYOV price slid a -13.26%.

MYOV stock chart (weekly)

MYOV stock price history

MYOV IPO was on October 27th, 2016 at $15.00 per share1. Since then, MYOV stock declined a -19.70%, with a yearly average of -6.60%.

1: Adjusted price after possible price splits or reverse-splits.

MYOV stock historical price chart

MYOV stock reached 52-week highs on December at $19.58, and all-time highs 2018-09-24 with a price of 27.45.

MYOV stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' MYOV stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price target for Myovant Sciences stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

, Myovant Sciences presented its financial report, posting a slightly fine growth for the Earnings per Share (EPS). Analyst expected $-0.99 per share, but Myovant Sciences posted $-1.04.
MYOV earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.38n/a
2017-Q2-n/a-0.39n/a
2017-Q3-n/a-0.5n/a
2017-Q4-n/a-0.7n/a
2018-Q12018-06-07-0.77-0.81n/a
2018-Q22018-08-07-0.77-0.98n/a
2018-Q32018-11-08-0.95-0.99n/a
2018-Q42019-02-07-0.99-1.04n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

Compared to , last anual turnover report draw of to million USD. When comparing vs , , profit margin (that is, the net income divided by revenues) a to .

MYOV annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter earnings marked $-70.63 M with a profit margin of . Profit margin stayed steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Myovant Sciences sales marked a tight move and stayed steady a nan%. Looking back to recent quarterly results, Myovant Sciences posted 7 positive quarters in a row.
MYOV quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Myovant Sciences ownership

When you are planning to invest in shares of a stock, it's always worth to check its ownership structure.

Myovant Sciences shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 59.91% of all shares.

In case of Myovant Sciences stock, 37.60% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for MYOV stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Myovant Sciences:

MYOV
Market cap$1.1 B
Total shares89.7 M
Float shares35.0 M
  - Institutional holdings (%)37.6%
  - Insider holdings (%)59.9%
Shares in short selling0.0%

MYOV summary

Thursday, May 14th, 2020
Open$12.00
Close$12.04
Day range$11.55 - $12.34
Previous close$12.01
Session gain0.25%
Average true range$0.86
50d mov avg$9.88
100d mov avg$11.50
200d mov avg$9.91
Daily pattern
Weekly pattern lb06a

Myovant Sciences performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Myovant Sciences, the benchmark is made against .
Stock3m6m12m
MYOVMyovant Sciences2.82%95.14%-3.53%

Myovant Sciences competitors

Unfortunately, we could not find any public company that could be defined as Myovant Sciences competitor. This doesn't mean Myovant Sciences does not have any competitor in the market, it's just we could not detected it.